International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Treatment of multiple myeloma has substantially changed over the past decade with the
introduction of several classes of new effective drugs that have greatly improved the rates …
introduction of several classes of new effective drugs that have greatly improved the rates …
Therapeutic strategies for enhancing angiogenesis in wound healing
The enhancement of wound healing has been a goal of medical practitioners for thousands
of years. The development of chronic, non-healing wounds is a persistent medical problem …
of years. The development of chronic, non-healing wounds is a persistent medical problem …
Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)
…, F Leal Da Costa, O Sezer, A Spencer… - Blood, The Journal …, 2011 - ashpublications.org
Most patients with newly diagnosed multiple myeloma (MM) are aged> 65 years with 30%
aged> 75 years. Many elderly patients are also vulnerable because of comorbidities that …
aged> 75 years. Many elderly patients are also vulnerable because of comorbidities that …
[HTML][HTML] ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
N Van Doremalen, T Lambe, A Spencer… - Nature, 2020 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in December
2019 1, 2 and is responsible for the coronavirus disease 2019 (COVID-19) pandemic 3 …
2019 1, 2 and is responsible for the coronavirus disease 2019 (COVID-19) pandemic 3 …
Euclid definition study report
…, A James, M Kemp, J Martignac, A Spencer… - arXiv preprint arXiv …, 2011 - arxiv.org
Euclid is a space-based survey mission from the European Space Agency designed to
understand the origin of the Universe's accelerating expansion. It will use cosmological …
understand the origin of the Universe's accelerating expansion. It will use cosmological …
Development and evaluation of the oral health impact profile.
GD Slade, AJ Spencer - Community dental health, 1994 - europepmc.org
The capacity of dental clinicians and researchers to assess oral health and to advocate for
dental care has been hampered by limitations in measurements of the levels of dysfunction …
dental care has been hampered by limitations in measurements of the levels of dysfunction …
[HTML][HTML] Revised international staging system for multiple myeloma: a report from International Myeloma Working Group
Purpose The clinical outcome of multiple myeloma (MM) is heterogeneous. A simple and
reliable tool is needed to stratify patients with MM. We combined the International Staging …
reliable tool is needed to stratify patients with MM. We combined the International Staging …
[HTML][HTML] Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
M Dimopoulos, A Spencer, M Attal… - … England Journal of …, 2007 - Mass Medical Soc
Background Lenalidomide is a structural analogue of thalidomide with similar but more
potent biologic activity. This phase 3, placebo-controlled trial investigated the efficacy of …
potent biologic activity. This phase 3, placebo-controlled trial investigated the efficacy of …
[HTML][HTML] Daratumumab, bortezomib, and dexamethasone for multiple myeloma
Background Daratumumab, a human IgGκ monoclonal antibody that targets CD38, induces
direct and indirect antimyeloma activity and has shown substantial efficacy as monotherapy …
direct and indirect antimyeloma activity and has shown substantial efficacy as monotherapy …
[HTML][HTML] Elotuzumab therapy for relapsed or refractory multiple myeloma
Background Elotuzumab, an immunostimulatory monoclonal antibody targeting signaling
lymphocytic activation molecule F7 (SLAMF7), showed activity in combination with …
lymphocytic activation molecule F7 (SLAMF7), showed activity in combination with …